Ganga Pharmaceuticals (BOM:539680) EPS (Basic) : ₹0.11 (TTM As of Sep. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Ganga Pharmaceuticals EPS (Basic)?

Ganga Pharmaceuticals's basic earnings per share (Basic EPS) for the six months ended in Sep. 2024 was ₹0.05. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Sep. 2024 was ₹0.11.

Ganga Pharmaceuticals's EPS (Diluted) for the six months ended in Sep. 2024 was ₹0.05. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was ₹0.11.

Ganga Pharmaceuticals's EPS without NRI for the six months ended in Sep. 2024 was ₹0.05. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Sep. 2024 was 0.11.

During the past 12 months, Ganga Pharmaceuticals's average EPS without NRIGrowth Rate was 91.50% per year. During the past 3 years, the average EPS without NRI Growth Rate was 11.90% per year. During the past 5 years, the average EPS without NRI Growth Rate was -38.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 10 years, Ganga Pharmaceuticals's highest 3-Year average EPS without NRI Growth Rate was 83.20% per year. The lowest was -50.40% per year. And the median was 11.90% per year.

Ganga Pharmaceuticals EPS (Basic) Historical Data

The historical data trend for Ganga Pharmaceuticals's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ganga Pharmaceuticals EPS (Basic) Chart

Ganga Pharmaceuticals Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

EPS (Basic)

Get a 7-Day Free Trial

0.46

0.05

0.09

0.10

0.11

Ganga Pharmaceuticals Semi-Annual Data
	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24
EPS (Basic)	Get a 7-Day Free Trial															0.08	0.02	0.04	0.06	0.05

Ganga Pharmaceuticals EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Ganga Pharmaceuticals's Basic EPS for the fiscal year that ended in Mar. 2024 is calculated as

Basic EPS (A: Mar. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(0.466	-	0)	/	4255.250
	=	0.00

Ganga Pharmaceuticals's Basic EPS for the quarter that ended in Sep. 2024 is calculated as

Basic EPS (Q: Sep. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(0.241	-	0)	/	4.813
	=	0.05

EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹0.11

Ganga Pharmaceuticals (BOM:539680) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Ganga Pharmaceuticals EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Ganga Pharmaceuticals's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Ganga Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ganga Pharmaceuticals Ltd (BOM:539680) » Definitions » EPS (Basic)

Traded in Other Exchanges

N/A

Address

Dhanvantri Marg, Gangatat, Gopcharpada, Near Digi 1 Electronic Showroom, Virar (East), Palghar, MH, IND, 401305

Website

https://www.ayurvedganga.com

Ganga Pharmaceuticals Ltd is an India based producer of ayurvedic medicines. It is engaged in the business of manufacturing and trading in ayurvedic pharmaceuticals and allied products. The company is also involved in the marketing and distribution of bulk ayurvedic medicines. The firm offers ayurvedic medicines for acidity, anti-dandruff, anti-oxidants, dental care, diarrhea, iron tonic, liver disorder, weight management, kidney stone, joint pains, liver disorder and others.

Ganga Pharmaceuticals Headlines

No Headlines